SANOFI SA (SNY)

Currency USD

Company Overview

Sanofi-Aventis manufactures & markets prescription drugs across countries. It focuses on major therapeutic areas such as multiple sclerosis, cardiovascular, immunology, neurology, oncology, rare blood disorders & diabetes, etc. By taking Genzyme Corporation as a subsidiary, it added products like Cerezyme, Myozyme/Lumizyme & Fabrazyme to its portfolio. Sanofi has become a major player in the CHC sector. It acquired many companies i.e. Ablynx & Bioverativ, Synthorx & Principia & Translate Bio and Kadmon. It has collaborated with companies like Regeneron among others. It develops and markets Dupixent, Kevzara & Libtayo in collaboration with Regeneron. Sanofi, along with Regeneron, is now solely responsible for Praluent marketing in & outside the U.S. Sanofi operates through 3 Global Business Units: Specialty Care (neurology & immunology, rare diseases, rare blood disorders & oncology), Vaccines & General Medicines (diabetes, cardiovascular & established products) and Consumer Healthcare, a standalone unit.

Contact Details

Address: 54 RUE LA BOETIE
City: PARIS
State: I0
Country: -
Zip Code: 75008
Phone Number: 33-1-53-77-44-00
Website: -

Financial Highlights

Day Range The price range a stock has traded at during the most recent trading period.: -

-
5 Day Range The price range a stock has traded at during the previous 5 days.: -

-
3 Month Range The price range a stock has traded at during the previous 3 months.: -

-
52 Week Range The price range a stock has traded at during the previous 52 weeks.: -

-
Previous Close The closing price of a stock from the previous day.: -
Open The price of the stock at the start of today’s market opening.: -
Bid The amount of money a trader is willing to pay per share for a given stock.: x
-
Ask The amount of money a seller wants per share of a given stock.: x
-
Volume The number of shares traded in a given period. This number illustrates the active interest in the stock at any time.: -
Avg. Volume The average number of shares traded in a given day.: -
Dividend Yield A company's annual dividend expressed as a percentage of its current stock price.: -
Recent Dividend The value a shareholder receives from a company they are invested in for holding their shares.: -
Beta A measurement of the stock’s volatility in comparison to the market as a whole.: -

Shareholding

Shares Outstanding Number of shares currently held by investors, including restricted shares owned by the company's officers and insiders.: -
Insider Shareholders The percentage of shares owned by any officer or board director of the company, including their related or affiliated individuals, families, entities and trusts.: -
Institutional Shareholders The percentage of shares owned by an institution such as a mutual fund, bank or insurance company.: -

Market Cap The market value of a company’s outstanding shares. It is used as a measurement tool to determine how large a company is.: -
Revenue TTM The amount of money a company has made for the trailing twelve-month period.: -
Net Income TTM A measurement of how much profit they are retaining for the trailing twelve-month period.: -
P/E Ratio The Price to Earnings (P/E) ratio, is calculated by dividing the stock's most recent share price by the sum of the diluted earnings per share.: -
EPS TTM Earnings Per Share (EPS) TTM is a company's profit for the trailing twelve-month period divided by its number of common outstanding shares.: -
1 Year Return A measurement of how much the stock has increased or decreased in the last year.: -

There is no stock data currently available for this time period, please select another option.

Please wait, gathering market data...